1,181
Views
6
CrossRef citations to date
0
Altmetric
Clinical Study

Red blood cell distribution width as a marker of cerebral infarction in hemodialysis patients

, , , , , , , , , & show all
Pages 712-718 | Received 27 Mar 2017, Accepted 23 Oct 2017, Published online: 16 Nov 2017

References

  • Lu J, Mu Y, Su Q. Reduced kidney function is associated with cardiometabolic risk factors, prevalent and predicted risk of cardiovascular disease in chinese adults: results from the REACTION study. J Am Heart Assoc. 2016;5:e003328.
  • Wang HH, Hung SY, Sung JM. Risk of stroke in long-term dialysis patients compared with the general population. Am J Kidney Dis. 2014;63:604–611.
  • Power A, Chan K, Singh SK. Appraising stroke risk in maintenance hemodialysis patients: a large single-center cohort study. Am J Kidney Dis. 2012;59:249–257.
  • Hou F, Jiang J, Chen J. China collaborative study on dialysis: a multi-centers cohort study on cardiovascular diseases in patients on maintenance dialysis. BMC Nephrol. 2012;13:94.
  • Liu ZH. Nephrology in china. Nat Rev Nephrol. 2013;9:523–528.
  • Danese E, Lippi G, Montagnana M. Red blood cell distribution width and cardiovascular diseases. J Thorac Dis. 2015;7:E402–E411.
  • Morgan DL, Peck SD. The use of red cell distribution width in the detection of iron deficiency in chronic hemodialysis patients. Am J Clin Pathol. 1998;89:513–515.
  • Anderson JL, Ronnow BS, Horne BD. Usefulness of a complete blood count-derived risk score to predict incident mortality in patients with suspected cardiovascular disease. Am J Cardiol. 2007;99:169–174.
  • Perlstein TS, Weuve J, Pfeffer MA. Red blood cell distribution width and mortality risk in a community-based prospective cohort. Arch Intern Med. 2009;169:588–594.
  • Tonelli M, Sacks F, Arnold M. Relation between red blood cell distribution width and cardiovascular event rate in people with coronary disease. Circulation. 2008;117:163–168.
  • Akin F, Kose N, Ayca B. Relation between red cell distribution width and severity of coronary artery disease in patients with acute myocardial infarction. Angiology. 2013;64:592–596.
  • Yoon HE, Kim SJ, Hwang HS. Progressive rise in red blood cell distribution width predicts mortality and cardiovascular events in end-stage renal disease patients. PLoS One. 2015;10:e0126272.
  • Kaya A, Isik T, Kaya Y. Relationship between red cell distribution width and stroke in patients with stable chronic heart failure: a propensity score matching analysis. Clin Appl Thromb Hemost. 2015;21:160–165.
  • Solak Y, Yilmaz MI, Saglam M. Red cell distribution width is independently related to endothelial dysfunction in patients with chronic kidney disease. Am J Med Sci. 2014;347:118–124.
  • Ariel F, Finkelstein A. High red blood cell distribution width and preclinical carotid atherosclerosis. Biomarkers. 2015;20:376–381.
  • Fried L, Bernardini J, Piraino B. Charlson comorbidity index as a predictor of outcomes in incident peritoneal dialysis patients. Am J Kidney Dis. 2001;37:337–342.
  • Um JY, Jeong HJ, Park RK. Aspects of gene polymorphisms in cerebral infarction: inflammatory cytokines. Cell Mol Life Sci. 2005;62:824–833.
  • Emans ME, van der Putten K, van Rooijen KL, et al. Determinants of red cell distribution width (RDW) in cardiorenal patients: RDW is not related to erythropoietin resistance. J Card Fail. 2011;17:626–633.
  • Friedman JS, Lopez MF, Fleming MD. SOD2-deficiency anemia: protein oxidation and altered protein expression reveal targets of damage, stress response, and antioxidant responsiveness. Blood. 2004;104:2565–2573.
  • Lippi G, Targher G, Montagnana M. Relation between red blood cell distribution width and inflammatory biomarkers in a large cohort of unselected outpatients. Arch Pathol Lab Med. 2009;133:628–632.
  • Forhecz Z, Gombos T, Borgulya G. Red cell distribution width in heart failure: prediction of clinical events and relationship with markers of ineffective erythropoiesis, inflammation, renal function, and nutritional state. Am Heart J. 2009;158:659–666.
  • Poole KE, Loveridge N, Barker PJ. Reduced vitamin D in acute stroke. Stroke. 2006;37:243–245.
  • Schneider AL, Lutsey PL, Selvin E. Vitamin D, vitamin D binding protein gene polymorphisms, race and risk of incident stroke: the Atherosclerosis Risk in Communities (ARIC) study. Eur J Neurol. 2015;22:1220–1227.
  • Liu T, Zhong S, Liu L. Vitamin D deficiency and the risk of anemia: a meta-analysis of observational studies. Ren Fail. 2015;37:929–934.
  • Kucera M, Balaz D, Kruzliak P. The effects of atorvastatin treatment on the mean platelet volume and red cell distribution width in patients with dyslipoproteinemia and comparison with plasma atherogenicity indicators – a pilot study. Clin Biochem. 2015;48:557–561.
  • Longenecker JC, Coresh J, Powe NR. Traditional cardiovascular disease risk factors in dialysis patients compared with the general population: the CHOICE Study. J Am Soc Nephrol. 2002;13:1918–1927.
  • Chen YH, Shi W, Liang XL. Effect of blood sample type on the measurement of advanced oxidation protein products as a biomarker of inflammation and oxidative stress in hemodialysis patients. Biomarkers. 2011;16:129–135.
  • Zhou Q, Wu S, Jiang J. Accumulation of circulating advanced oxidation protein products is an independent risk factor for ischaemic heart disease in maintenance haemodialysis patients. Nephrology (Carlton). 2012;17:642–649.